AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of November 9, 2026, AEON trades at $0.17 with a market cap of $12.58M and a P/E ratio of -0.07. AEON moved -0.11% today. Year to date, AEON is -84.15%; over the trailing twelve months it is -81.94%. Its 52-week range spans $0.13 to $1.45. Analyst consensus is strong buy with an average price target of $1.67. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AEON shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.17 |
| Market Cap | $12.58M |
| P/E Ratio | -0.07 |
| EPS | $-3.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.45 |
| 52-Week Low | $0.13 |
| Volume | 236.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.22M |
| Gross Margin | 0.00% |
3 analysts cover AEON: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1.67.